| VIRIDIAN THERAPEUTICS |
| USA |
| Gesundheit |
| US92790C1045 / A2QMUH |
| 1S1 (Frankfurt) / VRDN (NASDAQ) |
| FRA:1S1, ETR:1S1, 1S1:GR, NASDAQ:VRDN |
| - |
| https://www.viridianthera.. |
|
Viridian Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies to treat patients suffering from serious and rare diseases. The company's primary aim is to leverage innovative science to a..
>Volltext.. |
| 2432.72 Mio. EUR |
| 1842.5 Mio. EUR |
| 61.57 Mio. EUR |
| -314.7 Mio. EUR |
| -281.75 Mio. EUR |
| -3.31 EUR |
| 44.05 Mio. EUR |
| 184.56 Mio. EUR |
| -240.6 Mio. EUR |
| 12.37 |
| 20577.72% |
| -12.12% |
| - |
| - |
| - |
| - |
| VIRIDIAN |
| 31.03.26 |
|